Glucagon Emergency Kit for Low Blood Sugar — Class II drug recall D-0723-2026
Ongoing recall by Lupin Pharmaceuticals Inc., reported 2026-07-08, distributed nationwide. CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stabili
| Recall number | D-0723-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Naples, FL, United States |
| Recall initiated | 2026-06-23 |
| Classified | 2026-07-23 |
| Reported by FDA | 2026-07-08 |
| Distributed | Nationwide (US) |
| Quantity | 64,894 units |
| Reason classes | cgmp, specification failure |
| NDC | 70748-0309-01, 70748-0310-01, 70748-0311, 70748-0311-01 |
| Lot numbers | WB00010, WB00017, WB00019, WB00070, WB00077, WB00078, WB00130 |
| Expiration dates | 2027-01-20, 2027-02-20, 2027-06-20, 2027-07-20, 2027-11-20 |
Product
Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1 mL syringe, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupin Limited, Nagpur - 441108, INDIA, NDC 70748-311-01
Reason for recall
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0723-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.